New Investor and Licensing Partner Database Subscription for Fundraising and Strategic Development

By Antoinette Lowre, Manager of Business Development, LSN

When Life Science Nation (LSN) first opened its doors, the main goal was to connect with investors to collect information about what they were looking for in potential portfolio companies. LSN has since continued to keep adding and updating this information in the LSN Investor Database.

The LSN Investor Database includes information on over 3,000 active life science investment firms, tracking their preferences in areas such as sector, subsector, indication, phase of development, capital structure and geographical exposure. Companies can filter the data based on all of these criteria to identify those that fit their technology and stage of development.

The LSN Investor Database covers over 10 types of investors including angel groups, corporate venture capital, endowment/foundations, family offices, government organizations, hedge funds, large pharma, medtech strategics, private equity and venture capital. Companies can cast a wide net, looking at all types of investors and assessing which would be the best partner moving forward. When evaluating investors, companies can download or export search results and set up email alerts, taking advantage of the constantly updated and new profiles as LSN continues to curate the database.

With a new Salesforce integrated version of the LSN Investor Database on the horizon, we have decided to update our pricing for the current product. Check out the new monthly payment plan subscription options for the LSN Investor Database!

*A minimum commitment of six (6) months from the date of initial subscription is required.

The LSN Investor Database has been an incredibly valuable tool for our RESI partnering conferences. The investors who attend RESI must update their current mandates or be interviewed by the LSN investor research team to get added into the database. We then take that information and plug it into their profiles in partnering so there is no need to do research on your own, the profiles are already completed.

The next RESI partnering conference will take place this fall, September 18-20, at the Boston Park Plaza. This hybrid event will feature 1 day in person followed by 2 virtual partnering days. We anticipate 300+ investors and strategic partners along with 300+ life science startup companies spanning across the silos of drugs, devices, diagnostics, digital health and R&D services to all be in attendance.

The Early Bird rate for RESI Boston September ends Friday, July 28^th. This is your last chance to save $300 on your registration so you don’t want to miss this opportunity.

To learn more on how to get access to the LSN Investor Database or the RESI September conference, reach out to your business development manager to book a quick meeting. We hope to see you in Boston this fall.